BOUSSARD & GAVAUDAN HOLDING LIMITED (EUR) : Transaction in Own Shares
28 Junho 2024 - 2:00PM
BOUSSARD & GAVAUDAN HOLDING LIMITED (EUR) : Transaction in Own
Shares
BOUSSARD & GAVAUDAN HOLDING
LIMITED June 2024 TRANSACTION IN OWN SECURITIES ACTIVITY
REPORT1
The Company announces that pursuant to the
general authority granted by shareholders of the Company on 28 May
2019 to make market purchases of its own Ordinary shares, it
repurchased 0 Euro shares in June 2024.
Figure of the share buy back programme for June
2024
|
Share Buy Back Programme |
Liquidity Enhancement Agreement |
Aggregate number of transactions conducted in June 2024 |
0 |
0 |
Average size of the transactions |
0 |
0 |
Following this transaction, the Company has:
Euro share outstanding excluding share held in treasury |
12,299,516 |
Euro share held in treasury |
0 |
GBP share outstanding excluding share held in treasury |
123,090 |
GBP share held in treasury |
0 |
Total number of shares |
12,422,606 |
28 June 2024
For further information please contact:Boussard
& Gavaudan Investment Management, LLP
Emmanuel Gavaudan (London) +44 203 751
5389François-Xavier Baud (London) +44 203 751 5395
The Company is established as a closed-ended
investment company domiciled in Guernsey. The Company has received
the necessary approval of the Guernsey Financial Services
Commission and the States of Guernsey Policy Council. The Company
is registered with the Dutch Authority for the Financial Markets as
a collective investment scheme pursuant to article 2:73 in
conjunction with 2:66 of the Dutch Financial Supervision Act (Wet
op het financieel toezicht). The shares of the
Company (the "Shares") are listed on Euronext Amsterdam.
The Shares are also listed on the Official List of the UK
Listing Authority and admitted to trading on the London Stock
Exchange plc's main market for listed securities.
This is not an offer to sell or a solicitation
of any offer to buy any securities in the United States or in any
other jurisdiction. This announcement is not intended to and does
not constitute, or form part of, any offer or invitation to
purchase any securities or the solicitation of any vote or approval
in any jurisdiction, nor shall there be any sale, issuance or
transfer of the securities referred to in this announcement in any
jurisdiction in contravention of applicable law.
Neither the Company nor Boussard & Gavaudan
Fund Plc has been, and neither will be, registered under the US
Investment Company Act of 1940, as amended (the "Investment Company
Act"). In addition the securities referenced in this announcement
have not been and will not be registered under the US Securities
Act of 1933, as amended (the "Securities Act"). Consequently any
such securities June not be offered, sold or otherwise transferred
within the United States or to, or for the account or benefit of,
US persons except in accordance with the Securities Act or an
exemption therefrom and under circumstances which will not require
the issuer of such securities to register under the Investment
Company Act. No public offering of any securities will be made in
the United States.
You should always bear in mind that: all
investment is subject to risk;
- results in the
past are no guarantee of future results;
- the investment
performance of BGHL may go down as well as up. You may not get back
all of your original investment; and
- if you are in any doubt about the
contents of this communication or if you consider making an
investment decision, you are advised to seek expert financial
advice.
This communication is for information purposes
only and the information contained in this communication should not
be relied upon as a substitute for financial or other professional
advice.
1 This report includes the transactions
conducted by both BGHL, for the share buy back programme and Exane,
for the Liquidity Enhancement Agreement.
- Monthly Report Share Buy Back June 2024
Boussard And Gavaudan (EU:BGHL)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Boussard And Gavaudan (EU:BGHL)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024